A review of the TAILORx trial using the Oncotype DX assay to inform decisions in the adjuvant setting for treatment of HR+, HER2- breast cancer.
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Cardio-Oncology Considerations for Breast Cancer: Risk Stratification, Monitoring, and Treatment
June 26th 2025Survivors of breast cancer face increased cardiovascular risks due to treatment-related cardiotoxicity, and understanding these risks is crucial for effective management and prevention.